230 related articles for article (PubMed ID: 20615131)
1. Increased expression of vascular endothelial growth factor and its receptors, VEGFR-1 and VEGFR-2, in medullary thyroid carcinoma.
Capp C; Wajner SM; Siqueira DR; Brasil BA; Meurer L; Maia AL
Thyroid; 2010 Aug; 20(8):863-71. PubMed ID: 20615131
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases.
Jebreel A; England J; Bedford K; Murphy J; Karsai L; Atkin S
Int J Exp Pathol; 2007 Aug; 88(4):271-7. PubMed ID: 17696908
[TBL] [Abstract][Full Text] [Related]
4. Role of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytoma.
Ferreira CV; Siqueira DR; Romitti M; Ceolin L; Brasil BA; Meurer L; Capp C; Maia AL
Int J Mol Sci; 2014 Mar; 15(4):5323-36. PubMed ID: 24675699
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma].
Dales JP; Garcia S; Bonnier P; Duffaud F; Carpentier S; Djemli A; Ramuz O; Andrac L; Lavaut M; Allasia C; Charpin C
Ann Pathol; 2003 Sep; 23(4):297-305. PubMed ID: 14597894
[TBL] [Abstract][Full Text] [Related]
6. Microvascular density, vascular endothelial growth factor A, and its receptors in endometrial blood vessels in patients with menorrhagia.
Mints M; Blomgren B; Falconer C; Fianu-Jonasson A; Palmblad J
Fertil Steril; 2005 Sep; 84(3):692-700. PubMed ID: 16169405
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer.
Martins SF; Garcia EA; Luz MA; Pardal F; Rodrigues M; Filho AL
Cancer Genomics Proteomics; 2013; 10(2):55-67. PubMed ID: 23603341
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness.
Dhakal HP; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Bassarova A; Holm R; Giercksky KE; Nesland JM
Histopathology; 2012 Sep; 61(3):350-64. PubMed ID: 22690749
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
[TBL] [Abstract][Full Text] [Related]
10. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C
Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma.
Mylona E; Alexandrou P; Giannopoulou I; Liapis G; Sofia M; Keramopoulos A; Nakopoulou L
Gynecol Oncol; 2007 Mar; 104(3):557-63. PubMed ID: 17150246
[TBL] [Abstract][Full Text] [Related]
12. Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis.
Loges S; Clausen H; Reichelt U; Bubenheim M; Erbersdobler A; Schurr P; Yekebas E; Schuch G; Izbicki J; Pantel K; Bokemeyer C; Fiedler W
Clin Cancer Res; 2007 Jan; 13(1):76-80. PubMed ID: 17200341
[TBL] [Abstract][Full Text] [Related]
13. Increased expressions of vascular endothelial growth factor (VEGF), VEGF-C and VEGF receptor-3 in prostate cancer tissue are associated with tumor progression.
Yang J; Wu HF; Qian LX; Zhang W; Hua LX; Yu ML; Wang Z; Xu ZQ; Sui YG; Wang XR
Asian J Androl; 2006 Mar; 8(2):169-75. PubMed ID: 16491267
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma.
Meunier-Carpentier S; Dales JP; Djemli A; Garcia S; Bonnier P; Andrac-Meyer L; Lavaut MN; Allasia C; Charpin C
Int J Oncol; 2005 Apr; 26(4):977-84. PubMed ID: 15753992
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.
Kim JY; Bae BN; Kwon JE; Kim HJ; Park K
APMIS; 2011 Jul; 119(7):449-59. PubMed ID: 21635552
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
[TBL] [Abstract][Full Text] [Related]
18. Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival.
Jia JB; Zhuang PY; Sun HC; Zhang JB; Zhang W; Zhu XD; Xiong YQ; Xu HX; Tang ZY
J Cancer Res Clin Oncol; 2009 Jun; 135(6):847-54. PubMed ID: 19066962
[TBL] [Abstract][Full Text] [Related]
19. Increased angiogenesis and expression of vascular endothelial growth factor during scarless repair.
Colwell AS; Beanes SR; Soo C; Dang C; Ting K; Longaker MT; Atkinson JB; Lorenz HP
Plast Reconstr Surg; 2005 Jan; 115(1):204-12. PubMed ID: 15622252
[TBL] [Abstract][Full Text] [Related]
20. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
